US 11352426
CD3 binding polypeptides
granted A61KA61K2039/505A61P
Quick answer
US patent 11352426 (CD3 binding polypeptides) held by Aptevo Research and Development LLC expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aptevo Research and Development LLC
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00